BRPI1015091A2 - novo uso - Google Patents

novo uso

Info

Publication number
BRPI1015091A2
BRPI1015091A2 BRPI1015091A BRPI1015091A BRPI1015091A2 BR PI1015091 A2 BRPI1015091 A2 BR PI1015091A2 BR PI1015091 A BRPI1015091 A BR PI1015091A BR PI1015091 A BRPI1015091 A BR PI1015091A BR PI1015091 A2 BRPI1015091 A2 BR PI1015091A2
Authority
BR
Brazil
Prior art keywords
new use
new
Prior art date
Application number
BRPI1015091A
Other languages
English (en)
Inventor
Francesco Attanasio
Georgios Tzortzis
Jelena Vulevic
Original Assignee
Clasado Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40774842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1015091(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Clasado Inc filed Critical Clasado Inc
Publication of BRPI1015091A2 publication Critical patent/BRPI1015091A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
BRPI1015091A 2009-04-23 2010-04-23 novo uso BRPI1015091A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0906983.2A GB0906983D0 (en) 2009-04-23 2009-04-23 Novel use
GBGB0920784.6A GB0920784D0 (en) 2009-04-23 2009-11-27 Novel use
PCT/GB2010/050659 WO2010122344A1 (en) 2009-04-23 2010-04-23 Novel use

Publications (1)

Publication Number Publication Date
BRPI1015091A2 true BRPI1015091A2 (pt) 2016-04-26

Family

ID=40774842

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1015091A BRPI1015091A2 (pt) 2009-04-23 2010-04-23 novo uso

Country Status (25)

Country Link
US (1) US20120058972A1 (pt)
EP (1) EP2421541B1 (pt)
JP (1) JP2012524770A (pt)
KR (1) KR20110138416A (pt)
CN (1) CN102427818A (pt)
AU (1) AU2010240642B2 (pt)
BR (1) BRPI1015091A2 (pt)
CA (1) CA2759442C (pt)
CY (1) CY1120597T1 (pt)
DK (1) DK2421541T3 (pt)
ES (1) ES2688786T3 (pt)
GB (3) GB0906983D0 (pt)
HU (1) HUE040451T2 (pt)
IL (1) IL215855A0 (pt)
MX (1) MX341308B (pt)
MY (1) MY151104A (pt)
NZ (1) NZ595969A (pt)
PL (1) PL2421541T3 (pt)
PT (1) PT2421541T (pt)
RU (1) RU2530567C2 (pt)
SG (1) SG175313A1 (pt)
TR (1) TR201810868T4 (pt)
UA (1) UA106491C2 (pt)
WO (1) WO2010122344A1 (pt)
ZA (1) ZA201107821B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2492559B (en) * 2011-07-05 2018-07-25 Clasado Inc Composition and method for preventing or reducing the risk of developing a syndrome
DK2734210T3 (en) 2011-07-22 2018-01-22 Abbott Lab GALACTOOLIGOSACCHARIDES FOR THE PREVENTION OF DAMAGE TO AND / OR PROMOTION OF HEALING OF THE MAVE GAS CHANNEL
CN103716787B (zh) 2012-09-29 2020-06-23 北京三星通信技术研究有限公司 一种支持对家用基站进行验证的方法
CN107771083A (zh) * 2015-04-23 2018-03-06 卡莱多生物科技有限公司 聚糖治疗剂和治疗方法
CN107158011A (zh) * 2017-05-25 2017-09-15 浙江大学 低聚半乳糖在制备治疗肠道疾病的药物中的用途
US12508273B2 (en) 2019-05-15 2025-12-30 N.V. Nutricia Beta-1,3′-galactosyllactose for the treatment of gut barrier function diseases
US20240277739A1 (en) * 2021-07-01 2024-08-22 N.V. Nutricia Nutritonal compositions for gut barrier function
KR102453998B1 (ko) * 2022-01-07 2022-10-14 (주)네오크레마 갈락토올리고당을 포함하는 염증성 장질환의 예방, 개선 또는 치료용 조성물
GB2619977A (en) * 2022-06-24 2023-12-27 Clasado Res Services Limited Compositions and uses thereof
GB2623336A (en) * 2022-10-12 2024-04-17 Clasado Res Services Limited Compositions and uses thereof
GB2623335A (en) * 2022-10-12 2024-04-17 Clasado Res Services Limited Compositions and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
GB0315266D0 (en) * 2003-06-30 2003-08-06 Clasado Inc Novel galactooligosaccharide composition and the preparation thereof
ATE360682T1 (de) * 2003-06-30 2007-05-15 Clasado Inc Neue galactooligosaccharidzusammensetzung und herstellung davon
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
EP1887017A1 (en) * 2006-08-09 2008-02-13 Friesland Brands B.V. Prebiotic carbohydrate
GB0809921D0 (en) 2008-05-30 2008-07-09 Clasado Inc Product and process therefor

Also Published As

Publication number Publication date
PT2421541T (pt) 2018-10-15
RU2011147390A (ru) 2013-05-27
SG175313A1 (en) 2011-11-28
MX2011011159A (es) 2011-11-07
CN102427818A (zh) 2012-04-25
IL215855A0 (en) 2012-01-31
WO2010122344A1 (en) 2010-10-28
GB2482817B (en) 2014-02-26
MX341308B (es) 2016-08-12
CY1120597T1 (el) 2019-12-11
CA2759442A1 (en) 2010-10-28
NZ595969A (en) 2013-03-28
DK2421541T3 (en) 2018-09-24
EP2421541B1 (en) 2018-07-11
JP2012524770A (ja) 2012-10-18
TR201810868T4 (tr) 2018-08-27
AU2010240642A1 (en) 2011-11-10
KR20110138416A (ko) 2011-12-27
ZA201107821B (en) 2012-07-25
GB201120030D0 (en) 2012-01-04
US20120058972A1 (en) 2012-03-08
AU2010240642B2 (en) 2013-03-14
HUE040451T2 (hu) 2019-03-28
MY151104A (en) 2014-04-15
EP2421541A1 (en) 2012-02-29
CA2759442C (en) 2016-01-19
GB2482817A (en) 2012-02-15
GB0906983D0 (en) 2009-06-03
RU2530567C2 (ru) 2014-10-10
UA106491C2 (uk) 2014-09-10
GB0920784D0 (en) 2010-01-13
ES2688786T3 (es) 2018-11-06
PL2421541T3 (pl) 2018-11-30

Similar Documents

Publication Publication Date Title
EP2414948A4 (en) APPLICATION SHARING
FI20095251L (fi) Uudet materiaalit
DK2462134T3 (da) N1-sulfonyl-5-fluorpyrimidinonderivater
DE112010004215A5 (de) Hydrostataktor
DE112010002949A5 (de) Kupplungstastpunkte
EP2475287A4 (en) Child chair
BR112012000657A2 (pt) novos azabicilohexanos
BRPI1015091A2 (pt) novo uso
DK3473711T3 (da) Amylasepolypeptider
DE112010002728A5 (de) Turboinhalator
DE112009005323A5 (de) Hebelarmprüfmaschine
BRPI1008070A2 (pt) tricianoboratos
BRPI1011036A2 (pt) uso
UA20209S (uk) Крісло гіпертермотерапевтичне
EP2508411A4 (en) STRUCTURE
DOP2011000348A (es) Construcciones casb7439
DE112010003255A5 (de) Fördergutverteiler
BR112012001837A2 (pt) uso de fulvestrant
BR112012003616A2 (pt) metilpirroloprimidinacarboxamidas
DE112010002351A5 (de) Klemmorrichtung
FI20096108A0 (fi) Järjestely
DE102009034429A8 (de) Flachantenne
UA20208S (uk) Крісло гіпертермотерапевтичне
AT506924A3 (de) Bauprojektor
AT508508A3 (de) Heuballenbohrer

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]